Abstract:Kidney diseases such as glomerulopathy and nephron dysfunction are estimated to grow to more than 900 million cases by 2030, in 45% of which kidney transplantation will be required, representing a major challenge for biomedicine. A wealth of progress has been made to model human diseases using induced pluripotent stem cells (iPSCs) in vitro differentiated to a variety of organoids, including kidney organoids, and in developing various microfluidics-based organ-on-a-chip (OoC) systems based on them. With the combination of targeted gene editing capacities, relevant polymorphic genetic variants can be established in such organoid models to advance evidence-based medicine. However, the major drawback of the current organoid disease models is the lack of functional endothelial vasculature, which especially concerns the kidney, the function of which is strongly associated with blood flow. The design of novel medical devices using tissue engineering approaches such as kidney organoids is also strongly dependent on the understanding of the fundamental principles of nephrogenesis and the vascularization of organs and tissues. Developmental vascularization of the kidney has been an area of intense research for decades. However, there is still no consensus among researchers on how exactly the vascularization of the kidney occurs in normal and pathological conditions. This lack of consensus is partly due to the lack of an appropriate model system to study renal vascularization during nephrogenesis. In this review, we will describe recent progress in the areas of kidney vasculature development, kidney organoids in general and assembled on microfluidic devices in particular. We will focus on the in vitro vasculature of kidney organoids in microfluidic OoC model systems to study kidney diseases and on the perspectives of tissue engineering for the modeling of kidney diseases and the design of bioartificial medical devices. We also aim to summarize the information related to the key mechanisms of intercellular communication during nephrogenesis and the formation of the renal vasculature in an OoC setup.

Embracing Sex-specific Differences in Engineered Kidney Models for Enhanced Biological Understanding

Embracing sex-specific differences in engineered kidney models for enhanced biological understanding of kidney function

Sex-dependent metabolic remodeling of kidneys revealed by arteriovenous metabolomics

Kidney Disease Models: Tools to Identify Mechanisms and Potential Therapeutic Targets

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing

Experimental models for preclinical research in kidney disease

Sex and the Kidney Drug-Metabolizing Enzymes and Transporters: Are Preclinical Drug Disposition Data Translatable to Humans?

Sex as a Biological Variable in Tissue Engineering and Regenerative Medicine

Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease

Kidney Disease Modeling with Organoids and Organs-on-Chips

Animal Models of Kidney Disease: Challenges and Perspectives

Sex differences in renal transporters: assessment and functional consequences

Sex Differences in Kidney Health and Disease

Engineering physiological environments to advance kidney organoid models from human pluripotent stem cells

Evaluation of Renal Microhemodynamics Heterogeneity in Different Strains and Sexes of Mice

Toward Personalized Therapeutic Approaches

Vascularization of kidney organoids: different strategies and perspectives

Temporal and sex-dependent gene expression patterns in a renal ischemia–reperfusion injury and recovery pig model

Kidney-on-a-Chip: Mechanical Stimulation and Sensor Integration

Organs-On-Chip Models of the Female Reproductive System

Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma